1-2 of 2
Rudolf Schmits, MD
Close
Sort by
Journal Articles

Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Rudolf Schmits, MD, Samira Zeynalova, Eva Lengfelder, MD, Astrid Franke, MD, Hans Steinhauer, MD, Marcel Reiser, MD, Michael Clemens, MD, Christine Nickenig, MD, Martha de Wit, MD, Martin Hoffmann, MD, Roland Mertelsmann, MD, Bernd Metzner, MD, Anthony Ho, MD, Lorenz Truemper, MD, Hans Eimermacher, MD, Hans Mergenthaler, MD, Ruediger Liersch, MD, Ulrich Duehrsen, MD, Leopold Balleisen, MD, Frank Hartmann, MD, Viola Poeschel, MD, Norbert Schmitz, MD, Markus Loeffler, MD
Journal: Blood
Blood (2005) 106 (11): 13.
https://doi.org/10.1182/blood.V106.11.13.13
Published: 2005
Journal Articles

The Addition of Rituximab to Combination Chemotherapy with CHOP Has a Long Lasting Impact on Subsequent Treatment in Remission in Follicular Lymhoma but Not in Mantle Cell Lymphoma: Results of Two Prospective Randomized Studies of the German Low Grade Lymphoma Study Group (GLSG).

Wolfgang Hiddemann, MD, PhD, Roswitha Forstpointner, MD, Michael Kneba, MD, PhD, Norbert Schmitz, MD, PhD, Rudolf Schmits, MD, PhD, Bernd Metzner, MD, Marcel Reiser, MD, Eva Lengfelder, MD, PhD, Bernhard Woermann, MD, PhD, Hariett Harder, MD, Susanna Hegewisch-Becker, MD, PhD, Wolfgang Berdel, MD, PhD, Georg Hess, MD, Hartmut Eimermacher, MD, Ali Aldaoud, MD, Manfred Planker, MD, Reza Parwaresch, MD, PhD, Martin Dreyling, MD, PhD, Michael Unterhalt, MD
Journal: Blood
Blood (2004) 104 (11): 161.
https://doi.org/10.1182/blood.V104.11.161.161
Published: 2004